Agentic AI in production: Merck, Mastercard on what works
Merck is using AI agents to cut drug discovery cycles by a third and ship compliant marketing materials up to 80% faster — but VP of Digital Platforms Sean Finnerty says the only reason it's working is because they built the infrastructure first.
And the pharmaceutical manufacturer is seeing promising early results: AI is generating marketing drafts that are “99% right” when it comes to compliance, shrinking review cycles from months to days and accelerating delivery by 70% to 80%. In the company’s medical research, meanwhile, one AI-assisted discovery cycle was reduced by 33%.
Still, agentic AI only works if companies first build the underlying “plumbing,” Finnerty said of digital platforms and services at a recent AI Impact Series event.
“If we do one-offs, we're gonna end up with thousands and thousands of things that are ultimately just gonna be debt that we'll have to deal with later,” he said....
Copyright of this story solely belongs to venturebeat.com. To see the full text click HERE
